Discontinuation report DALACIN C 300 MG

Last updated on 2024-10-30 History
Report ID 241493
Drug Identification Number 02182866
Brand name DALACIN C 300 MG
Common or Proper name DALACIN C 300 MG
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) CLINDAMYCIN
Strength(s) 300MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code J01FF
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2024-10-29
Remaining supply date
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2024-10-29 English Compare
v2 2024-10-29 French Compare
v3 2024-10-30 English Compare

Showing 1 to 3 of 3